CDKN2A and mesothelioma: Homozygous deletion of BAP1 and cyclin-dependent kinase inhibitor 2A (CDKN2A/p16) by fluorescence in situ hybridisation (FISH) is highly specific for mesothelioma [5,11,13-15].